Company news
Medite Cancer Diagnostics Inc (OTC:MDIT) news
Medite Cancer Diagnostics Inc news releases on 6ix. Latest, Nov 15, 2017: MEDITE Cancer Diagnostics Appoints Joel Kanter To Its Board As An Independent Director
Press releases & updates
MEDITE Cancer Diagnostics Appoints Joel Kanter To Its Board As An Independent Director
November 15, 2017
MEDITE Cancer Diagnostics Reports 2017 Third Quarter Financial Results
November 14, 2017
MEDITE Cancer Diagnostics Reports Appointments of New Chairman of the Board and Chief Executive Officer
November 8, 2017
MEDITE Cancer Diagnostics Reports Closing of $5.4 Million Private Financing, Providing Working Capital to Drive Commercial Plan Execution
October 3, 2017
MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results
August 14, 2017
MEDITE Cancer Diagnostics to Launch SureCyte(TM) C1 Stain Globally at the 29th European Congress of Pathology
July 27, 2017
MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations
May 10, 2017
MEDITE Cancer Diagnostics Appoints Susan Weisman as Chief Financial Officer
April 27, 2017
OTC Markets Group Welcomes Newly Verified OTCQB Companies – February 12
February 12, 2016